Oncology

Erlotinib HCl

EGFR tyrosine kinase inhibitor for NSCLC and pancreatic cancer

About Erlotinib HCl

Erlotinib HCl is an active pharmaceutical ingredient (API) classified under the Oncology category. EGFR tyrosine kinase inhibitor for NSCLC and pancreatic cancer

Medical Use

EGFR tyrosine kinase inhibitor for NSCLC and pancreatic cancer

Find Manufacturers in India

Pharmazon connects you with verified, GMP-certified pharmaceutical manufacturers who use Erlotinib HCl in their formulations. Browse verified suppliers, compare product catalogs, and request quotes directly.

Find Erlotinib HCl Manufacturers